IFPA meeting 2015 workshop report III: nanomedicine applications and exosome biology, xenobiotics and endocrine disruptors and pregnancy, and lipid.
Workshops are an important part of the IFPA annual meeting, as they allow for discussion of specialized topics. At the IFPA meeting 2015 there were twelve themed workshops, three of which are summarized in this report. These workshops were related to various aspects of placental biology but collectively covered areas of pregnancy pathologies and placental metabolism: 1) nanomedicine applications and exosome biology; 2) xenobiotics and endocrine disruptors and pregnancy; 3) lipid mediators and placental function.
Institute of Biochemistry and Molecular Medicine, University of Bern, Switzerland.
C
C
Albrecht
Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.
I
I
Caniggia
Mater Research, Matter Hospital, Brisbane, Australia.
V
V
Clifton
University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
C
C
Göhner
University of Manchester, UK.
L
L
Harris
University of Alberta, Edmonton, Alberta, Canada.
D
D
Hemmings
University of Buenos Aires, Buenos Aires, Argentina.
A
A
Jawerbaum
University of Manchester, Manchester, UK.
E
E
Johnstone
Cincinnati Children's Hospital Medical Center, Cincinnati, USA.
H
H
Jones
The University of Western Australia, Perth, WA, Australia.
J
J
Keelan
University of Southampton, UK.
R
R
Lewis
UQ Centre for Clinical Research, The University of Queensland, Australia.
M
M
Mitchell
Department of Medicine, Monash University, Clayton Victoria 3168, Australia.
P
P
Murthi
University of Colorado Anschutz Medical Campus, Denver, CO, USA.
T
T
Powell
Murdoch Childrens Research Institute, Department of Paediatrics, University of Melbourne, Australia.
R
R
Saffery
The Mothers and Babies Research Centre, University of Newcastle, Australia.
R
R
Smith
INRS Institut Armand Frappier, Université du Québec, Canada.
C
C
Vaillancourt
Medical University of Graz, Graz, Austria.
C
C
Wadsack
Exosome Biology Laboratory, Center for Clinical Diagnostics, UQ Centre for Clinical Research, Faculty of Medicine + Biomedical Sciences, The University of Queensland, Australia. Electronic address: c.salomongallo@uq.edu.au.
C
C
Salomon
D052244:Endocrine Disruptors / Q000494:pharmacology*; D055354:Exosomes / Q000502:physiology*; D005260:Female; D006801:Humans; D008055:Lipids; D050997:Nanomedicine; D010920:Placenta / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010929:Placentation / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D015262:Xenobiotics
D052244:Endocrine Disruptors; D008055:Lipids; D015262:Xenobiotics
Exosomes; Lipids; Nanomedicine; Xenobiotics